Skip Navigation


Briefings in Bioinformatics Advance Access originally published online on August 9, 2006
Briefings in Bioinformatics 2006 7(3):313-314; doi:10.1093/bib/bbl017
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
7/3/313    most recent
bbl017v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li, X.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Li, X.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. For Permissions, please email: journals.permissions@oxfordjournals.org

Book Review

Cancer Bioinformatics—From Therapy Design to Treatment.

Edited by Sylvia Nagl

John Wiley & Sons Ltd, The Atrium,

Southern Gate, Chichester;

ISBN: 0-470-86304-8; 300pp.; 2006; $130.

The first 10% of the full text of this article appears below.

In this post-genomic era, a large amount of data such as expressed sequence tag (EST) data, structure data, microarray data, proteomic data, single nucleotide polymorphism (SNP) data and clinical data provide great opportunities to understand cancer, the second most common cause of death in the western world. These data, addressing the same problem from different angles, should be integrated to generate useful . . . [Full Text of this Article]

Xiaoman Li
Division of Biostatistics
School of Medicine
Indiana University


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?